Adaptimmune Therapeutics plc

    Jurisdiction
    United Kingdom
    LEI
    549300UUNWK8TRT5EW12
    ISIN
    US00653A1079 (ADAP)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 48 / 100
    Worse than peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    2 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €55.84M
    Gross margin
    94.8%
    EBIT
    -€140.90M
    EBIT margin
    -252.3%
    Net income
    -€145.65M
    Net margin
    -260.8%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €61.60M +10.3% -€67.44M -53.7%
    €110.58M +79.5% -€34.87M -48.3%
    €158.53M +43.4% -€2.42M -93.1%

    Dividends

    No dividend payouts

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Wood Gavin Chief Financial Officer -96K $0.01 -$960.00
    Bertrand William C JR Chief Operating Officer -207K $0.01 -$2.07K
    Behbahani Ali N/A -20M $0.01 -$195.00K
    EcoR1 Capital, LLC N/A -64M $0.11 -$7.05M

    Earnings Calls

    Latest earnings call: May 15, 2024

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 1.8M $357.33K -713K Sell

    Add to watchlist

    Notifications